NO20005547D0 - Myelinbasiske proteinpeptider og anvendelser derav - Google Patents
Myelinbasiske proteinpeptider og anvendelser deravInfo
- Publication number
- NO20005547D0 NO20005547D0 NO20005547A NO20005547A NO20005547D0 NO 20005547 D0 NO20005547 D0 NO 20005547D0 NO 20005547 A NO20005547 A NO 20005547A NO 20005547 A NO20005547 A NO 20005547A NO 20005547 D0 NO20005547 D0 NO 20005547D0
- Authority
- NO
- Norway
- Prior art keywords
- myelin
- based protein
- protein peptides
- peptides
- protein
- Prior art date
Links
- 102000006386 Myelin Proteins Human genes 0.000 title 1
- 108010083674 Myelin Proteins Proteins 0.000 title 1
- 210000005012 myelin Anatomy 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7310998A | 1998-05-05 | 1998-05-05 | |
| PCT/US1999/009930 WO1999057241A2 (en) | 1998-05-05 | 1999-05-05 | Myelin basic protein peptides and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005547D0 true NO20005547D0 (no) | 2000-11-03 |
| NO20005547L NO20005547L (no) | 2001-01-02 |
Family
ID=22111789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005547A NO20005547L (no) | 1998-05-05 | 2000-11-03 | Myelinbasisproteinpeptider og anvendelser derav |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1080185A4 (no) |
| JP (1) | JP2002513558A (no) |
| CN (1) | CN1308671A (no) |
| AU (1) | AU3789099A (no) |
| CA (1) | CA2330826A1 (no) |
| HK (1) | HK1039636A1 (no) |
| NO (1) | NO20005547L (no) |
| NZ (1) | NZ507901A (no) |
| WO (1) | WO1999057241A2 (no) |
| ZA (1) | ZA200006268B (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4538192B2 (ja) * | 2001-05-01 | 2010-09-08 | ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア | 免疫疾患を治療するための融合分子及び方法 |
| US7265208B2 (en) | 2001-05-01 | 2007-09-04 | The Regents Of The University Of California | Fusion molecules and treatment of IgE-mediated allergic diseases |
| ITFI20010114A1 (it) | 2001-06-22 | 2002-12-22 | Univ Firenze | Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla |
| PL2227486T3 (pl) * | 2007-11-20 | 2017-09-29 | Vianex S.A. | Analogi peptydowe i ich koniugaty |
| JPWO2016159181A1 (ja) * | 2015-03-30 | 2018-02-22 | 国立大学法人大阪大学 | 免疫用ペプチド、免疫用ペプチドの製造方法、それを含む免疫疾患用医薬組成物、および免疫疾患の治療方法 |
| CN114258317B (zh) * | 2019-06-18 | 2025-03-14 | 斯克里普斯研究学院 | 用于治疗炎性病症的方法和组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5734023A (en) * | 1991-11-19 | 1998-03-31 | Anergen Inc. | MHC class II β chain/peptide complexes useful in ameliorating deleterious immune responses |
| CA2203629A1 (en) * | 1994-10-25 | 1996-05-02 | Dawn Smilek | Compositions and treatment for multiple sclerosis |
| AU6331696A (en) * | 1995-06-07 | 1996-12-30 | Anergen, Inc. | Fused soluble mhc heterodimer:peptide complexes and their uses |
-
1999
- 1999-05-05 NZ NZ507901A patent/NZ507901A/xx unknown
- 1999-05-05 AU AU37890/99A patent/AU3789099A/en not_active Abandoned
- 1999-05-05 EP EP99920379A patent/EP1080185A4/en not_active Withdrawn
- 1999-05-05 HK HK02101092.3A patent/HK1039636A1/zh unknown
- 1999-05-05 JP JP2000547197A patent/JP2002513558A/ja active Pending
- 1999-05-05 CA CA002330826A patent/CA2330826A1/en not_active Abandoned
- 1999-05-05 CN CN99808248A patent/CN1308671A/zh active Pending
- 1999-05-05 WO PCT/US1999/009930 patent/WO1999057241A2/en not_active Ceased
-
2000
- 2000-11-02 ZA ZA200006268A patent/ZA200006268B/en unknown
- 2000-11-03 NO NO20005547A patent/NO20005547L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20005547L (no) | 2001-01-02 |
| AU3789099A (en) | 1999-11-23 |
| HK1039636A1 (zh) | 2002-05-03 |
| CA2330826A1 (en) | 1999-11-11 |
| CN1308671A (zh) | 2001-08-15 |
| WO1999057241A3 (en) | 2000-01-13 |
| WO1999057241A9 (en) | 2000-02-17 |
| ZA200006268B (en) | 2001-08-22 |
| WO1999057241A2 (en) | 1999-11-11 |
| EP1080185A4 (en) | 2005-01-26 |
| JP2002513558A (ja) | 2002-05-14 |
| NZ507901A (en) | 2003-06-30 |
| EP1080185A2 (en) | 2001-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS1810B (is) | Úðablöndur úr peptíðum og próteinum | |
| NO20000700D0 (no) | Interleukin-18-proteiner samt fremstilling og anvendelse derav | |
| NO982097D0 (no) | Peptider | |
| NO982098L (no) | Peptider | |
| EP1461605A4 (en) | NANOSTERIALS OF PROTEINS AND PEPTIDES | |
| NO983364L (no) | Konsensusproteiner | |
| NO20071415L (no) | OB-fusjonsproteinpreparater og fremgangsmater | |
| NO985680D0 (no) | Peptidderivater | |
| EP1056465A4 (en) | ANTIMICROBIAL PEPTIDES AND DERIVATIVE METAPEPTIDES | |
| NO983849L (no) | Peptidderivater | |
| NO971448D0 (no) | Anti-Fas rekombinante antistoffer og DNA derfor | |
| NO995062D0 (no) | <Beta>-anyloidpeptid-bindende proteiner og polynuldeotider som kodes for samme | |
| GB9918155D0 (en) | Proteins and peptides | |
| ATE295417T1 (de) | Angiostatin-bindendes protein | |
| NO20005547D0 (no) | Myelinbasiske proteinpeptider og anvendelser derav | |
| DE69816241D1 (de) | Aktivierte peptide und konjugate | |
| TR199701666A3 (tr) | Sismanliga karsi proteinler | |
| KR960010685A (ko) | 펩티드 및 그 용도 | |
| EP1337543A4 (en) | Streptavidin-binding peptides and uses thereof | |
| NO20012283D0 (no) | Koblede peptider | |
| NO20006091D0 (no) | Humant protein C-polypeptid | |
| EP1127066A4 (en) | MODIFIED PROTEINS | |
| SE9802441D0 (sv) | New peptides and use thereof | |
| SE9802562D0 (sv) | New peptides and use thereof | |
| SE9701041D0 (sv) | Novel proteins and their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |